HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Alain J. Poncelet Permission Requests Google Scholar Articles by Poncelet, A. J. Articles by Hanin, F.-X. PubMed Articles by Poncelet, A. J. Articles by Hanin, F.-X. Related Collections Lung - cancer Lung - other Mediastinum Trachea and bronchi

Letters to the Editor

Reply to Chong

^a Department of Cardiovascular and Thoracic Surgery, Cliniques universitaires St-Luc-UCL, Brussels, Belgium
^b Department of Nuclear Medicine, Cliniques universitaires St-Luc-UCL, Brussels, Belgium

Received 3 July 2008; accepted 14 July 2008.

^_* Corresponding author. Address: Cardio-Vascular and Thoracic Surgery Unit, U.C.L. Saint Luc Hospital, Université catholique de Louvain, Avenue Hippocrate 10, B-1200 Brussels, Belgium. Tel.: +32 2 7646107; fax: +32 2 7648960. (Email: Poncelet@chir.ucl.ac.be).

Key Words: Non-small cell lung cancer • PET-FDG • SUV • Prognosis • Thoracic surgery

The first 20% of the full text of this article appears below.

We very much appreciated the remarks and comments from Chong [1] on our recently published results on the prognostic significance of PET-FDG SUVmax in early stage non-small cell lung cancer [2].

In his letter to the editor, Chong has underlined several potential faults with data presentation and analysis that we would like to answer for the sake of clarity even though a peer reviewed statistical analysis did validate the current published study.

Chong rightly stated that our article did not provide the results of the univariate . . . [Full Text of this Article]